(Q33701309)

28 July 2017

1 reference

title

Review article: the safety and efficacy of alosetron, a 5-HT3 receptor antagonist, in female irritable bowel syndrome patients (English)

1 reference

28 July 2017

1 reference

irritable bowel syndrome

1 reference

1 reference

Mangel AW

1

1 reference

PubMed ID

10429745

28 July 2017

Northcutt AR

series ordinal

2

1 reference

PubMed ID

10429745

28 July 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

Alimentary Pharmacology & Therapeutics

28 July 2017

1 reference

28 July 2017

13 Suppl 2

1 reference

28 July 2017

77-82

1 reference

Irritable bowel syndrome in office-based practice in the United States

28 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00010.X

Review article: irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00010.X

Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00010.X

Visceral pain reflex after pretreatment with capsaicin and morphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00010.X

Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00010.X

Use of a novel electronic data collection system in multicenter studies of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00010.X

Adequate relief as an endpoint in clinical trials in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00010.X

10.1046/J.1365-2036.1999.00010.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10429745